Table 2.
Characteristics of patients based on the decontamination procedure received
| Characteristics | Nil (259) | SDAC(102) | WBI(36) | SDAC/WBI(39) |
|---|---|---|---|---|
| Reported dose (mg); median (IQR) | 1050 (450–2100) | 1350 (600–2568.7) | 3300 (2250–4200) | 4200 (2062.5–4612.5) |
| Age (years); median (IQR) | 37 (27–43) | 36 (24–42) | 39 (27–44) | 36 (25–41) |
| Gender, Females, n (%) | 193 (74.8) | 79 (77.4) | 29 (80.5) | 29 (74.3) |
| Formulation | ||||
| Standard release (IR), n (%) | 145 (55.9) | 60 (58.9) | 5 (13.8) | 6 (15.4) |
| Extended release (SR), n (%) | 114 (44.1) | 42 (41.1) | 31 (86.2) | 33 (84.6) |
| Co-ingestants | ||||
| Benzodiazepines | 71 | 31 | 13 | 11 |
| Pro-convulsants | 4 | 1 | 1 | 0 |
IQR, Inter quantile range; SDAC, single dose activated charcoal; WBI, whole bowel irrigation; SADAC/WBI, combination of SDAC and WBI; SR, sustained release; IR, immediate release; n = number of patients.